Human KRT19/CK19/K19 ORF/cDNA clone-Adenovirus plasmid (BC007628 )

Cat. No.: pGMAP000089
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human KRT19/CK19/K19 adenoviral expression plasmid for KRT19 adenovirus packaging, KRT19 adenovirus.

Our GM-Adenovirus vector is optimized with the GMVC-modified Adeasy adenovirus packaging system. Find more about the GMVC-modified adenovirus packaging system.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Target products collection

Go to Cytokeratin 19/KRT19/KRT19/CK19 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMAP000089
Gene Name KRT19
Accession Number BC007628
Gene ID 3880
Species Human
Product Type Adenovirus plasmid (overexpression)
Insert Length 1203 bp
Gene Alias CK19,K19,K1CS,MGC15366
Fluorescent Reporter GFP
Mammalian Cell Selection Null
Fusion Tag 3xflag (C-Terminal)
Promoter EF1
Resistance Kanamycin
ORF Nucleotide Sequence ATGACTTCCTACAGCTATCGCCAGTCGTCGGCCACGTCGTCCTTCGGAGGCCTGGGCGGCGGCTCCGTGCGTTTTGGGCCGGGGGTCGCTTTTCGCGCGCCCAGCATTCACGGGGGCTCCGGCGGCCGCGGCGTATCCGTGTCCTCCGCCCGCTTTGTGTCCTCGTCCTCCTCGGGGGGCTACGGCGGCGGCTACGGCGGCGTCCTGACCGCGTCCGACGGGCTGCTGGCGGGCAACGAGAAGCTAACCATGCAGAACCTCAACGACCGCCTGGCTTCCTACCTGGACAAGGTGCGCGCCCTGGAGGCGGCCAACGGCGAGCTAGAGGTGAAGATCCGCGACTGGTACCAGAAGCAGGGGCCTGGGCCCTCCCGCGACTACAGCCACTACTACACGACCATCCAGGACCTGCGGGACAAGATTCTTGGTGCCACCATTGAGAACTCCAGGATTGTCCTGCAGATCGACAACGCCCGTCTGGCTGCAGATGACTTCCGAACCAAGTTTGAGACGGAACAGGCTCTGCGCATGAGCGTGGAGGCCGACATCAACGGCCTGCGCAGGGTGCTGGATGAGCTGACCCTGGCCAGGACCGACCTGGAGATGCAGATCGAAGGCCTGAAGGAAGAGCTGGCCTACCTGAAGAAGAACCATGAGGAGGAAATCAGTACGCTGAGGGGCCAAGTGGGAGGCCAGGTCAGTGTGGAGGTGGATTCCGCTCCGGGCACCGATCTCGCCAAGATCCTGAGTGACATGCGAAGCCAATATGAGGTCATGGCCGAGCAGAACCGGAAGGATGCTGAAGCCTGGTTCACCAGCCGGACTGAAGAATTGAACCGGGAGGTCGCTGGCCACACGGAGCAGCTCCAGATGAGCAGGTCCGAGGTTACTGACCTGCGGCGCACCCTTCAGGGTCTTGAGATTGAGCTGCAGTCACAGCTGAGCATGAAAGCTGCCTTGGAAGACACACTGGCAGAAACGGAGGCGCGCTTTGGAGCCCAGCTGGCGCATATCCAGGCGCTGATCAGCGGTATTGAAGCCCAGCTGGGCGATGTGCGAGCTGATAGTGAGCGGCAGAATCAGGAGTACCAGCGGCTCATGGACATCAAGTCGCGGCTGGAGCAGGAGATTGCCACCTACCGCAGCCTGCTCGAGGGACAGGAAGATCACTACAACAATTTGTCTGCCTCCAAGGTCCTCTGA
ORF Protein Sequence MTSYSYRQSSATSSFGGLGGGSVRFGPGVAFRAPSIHGGSGGRGVSVSSARFVSSSSSGGYGGGYGGVLTASDGLLAGNEKLTMQNLNDRLASYLDKVRALEAANGELEVKIRDWYQKQGPGPSRDYSHYYTTIQDLRDKILGATIENSRIVLQIDNARLAADDFRTKFETEQALRMSVEADINGLRRVLDELTLARTDLEMQIEGLKEELAYLKKNHEEEISTLRGQVGGQVSVEVDSAPGTDLAKILSDMRSQYEVMAEQNRKDAEAWFTSRTEELNREVAGHTEQLQMSRSEVTDLRRTLQGLEIELQSQLSMKAALEDTLAETEARFGAQLAHIQALISGIEAQLGDVRADSERQNQEYQRLMDIKSRLEQEIATYRSLLEGQEDHYNNLSASKVL

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-T54461-Ab Anti-KRT19 monoclonal antibody
    Target Antigen GM-Tg-g-T54461-Ag KRT19 protein
    ORF Viral Vector pGMLP003887 Human KRT19 Lentivirus plasmid
    ORF Viral Vector pGMAP000089 Human KRT19 Adenovirus plasmid
    ORF Viral Vector pGMAP000435 Human KRT19 Adenovirus plasmid
    ORF Viral Vector vGMLP003887 Human KRT19 Lentivirus particle
    ORF Viral Vector vGMAP000089 Human KRT19 Adenovirus particle
    ORF Viral Vector vGMAP000435 Human KRT19 Adenovirus particle


    Target information

    Target ID GM-T54461
    Target Name Cytokeratin 19/KRT19
    Gene Group Identifier
    （Target Gene ID in Homo species)         		3880
    Gene ID 101090662 (Felis catus), 138925022 (Equus caballus), 16669 (Mus musculus), 360626 (Rattus norvegicus)
    3880 (Homo sapiens), 514812 (Bos taurus)
    Gene Symbols & Synonyms KRT19,Krt19,K19,CK-19,EndoC,Krt1-19,Krt-1.19,Ka19,CK19,K1CS
    Target Alternative Names CK-19,CK19,Cytokeratin 19,Cytokeratin-19 (CK-19),EndoC,K19,K1CS,KRT19,Ka19,Keratin,Keratin-19 (K19),Krt-1.19,Krt1-19,Krt19,type I cytoskeletal 19
    Uniprot Accession P08727,P08728,P19001,Q63279
    Additional SwissProt Accessions: P19001,Q63279,P08727,P08728
    Uniprot Entry Name
    Protein Sub-location Introcelluar Protein
    Category Therapeutics Target
    Disease cancer, Breast Cancer, Ovary Cancer, Endometriosis, Malignant neoplasm of bladder
    Disease from KEGG Staphylococcus aureus infection
    Gene Ensembl ENSMUSG00000020911, ENSG00000171345, ENSBTAG00000004905
    Target Classification


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.